Baseline history |
Establish current level of disease severity and retrospectively estimate rate of progression |
At diagnosis |
[9, 62, 78] |
Interval history |
Establish rate of disease progression; monitor for compliance with and side effects from therapy; monitor for conditions which would prompt discontinuation of therapy |
6 months |
[62, 78] |
Physical examination |
Document growth parameters, assess for neurological features and organomegaly |
At diagnosis then every 6–12 months |
[61, 62] |
NPC clinical severity score |
Document key features of disease at diagnosis, progression and response to therapy |
At diagnosis and then every 6 months |
[22, 24, 32, 61] |
Neuropsychiatric evaluation |
Document and treat psychiatric manifestations and response to therapy |
At diagnosis then every 6–12 months |
[62, 79] |
Developmental or cognitive assessment |
Document baseline degree of cognitive impairment and monitor response to therapy |
At diagnosis; every 6 months in children; every 12 months in adults |
[9, 47, 61, 80] |
Ophthalmology evaluation |
Document saccadic eye movement velocity and presence of gaze palsy at baseline and document response to miglustat therapy in treated patients |
At diagnosis; at 6 and 12 months; after starting treatment; frequency after 12 months can be determined by clinical response |
[61] |
Audiometry |
Document presence of hearing loss |
At diagnosis then every 12 months |
[81] |
Swallowing assessment |
Clinical swallowing assessment in all patients; videofluoroscopic swallowing (VFS) assessment may be useful in some patients; Document presence of dysphagia and aspiration and response to therapy |
At diagnosis and then every 6 months in children; in adults, frequency could be reduced to every 12 months if asymptomatic and disease is stable |
[61, 82] |
Neuroimaging |
Magnetic resonance imaging or more detailed forms of neuroimaging including MR spectroscopy and diffusion tensor imaging |
At baseline if available; Decisions about follow up neuroimaging will depend on local availability and need for general anaesthesia |
[47, 83–85] |